Huang Wen

Mr. Huang Wen

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2018 in Plant Physiology and Biochemistry
Verified
Journal Article
Closed access
YLYepu Li
Yepu Li
SWShengli Wang
Shengli Wang
QZQian Zhang
Qian Zhang
FZFei Zang
Fei Zang
ZNZhongren Nan
Zhongren Nan
LBLili Bao
Lili Bao

18 November 2020 in Advanced Therapeutics
Verified
Journal Article
Closed access
PDF file
HWHuang Wen
Huang Wen
KTKonstantin Tamarov
Konstantin Tamarov
EHEmilia Happonen
Emilia Happonen
VLVesa-Pekka Lehto
Vesa-Pekka Lehto
Wujun XuWujun Xu
Wujun Xu

2 January 2024 in International Journal of Pharmaceutics
Verified
Journal Article
Open access
HWHuang Wen
Huang Wen
MMMaría Gómez Martínez
María Gómez Martínez
EHEmilia Happonen
Emilia Happonen
JQJing Qian
Jing Qian
VVVanessa Gómez Vallejo
Vanessa Gómez Vallejo
Wujun XuWujun Xu
Wujun Xu
Triple-negative breast cancer (TNBC) diagnosis remains challenging without expressing critical receptors. Cancer cell membrane (CCm) coating has been extensively studied for targeted cancer diagnostics due to attractive features such as good biocompatibility and homotypic tumor-targeting. However, the present study found that widely used CCm coating approaches, such as extrusion, were not applicable for functionalizing irregularly shaped nanoparticles (NPs), such as porous silicon (PSi). To tackle this challenge, we proposed a novel approach that employs polyethylene glycol (PEG)-assisted membrane coating, wherein PEG and CCm are respectively functionalized on PSi NPs through chemical conjugation and physical absorption. Meanwhile, the PSi NPs were grafted with the bisphosphonate (BP) molecules for radiolabeling. Thanks to the good chelating ability of BP and homotypic tumor targeting of cancer CCm coating, a novel PSi-based contrast agent (CCm-PEG-89Zr-BP-PSi) was developed for targeted positron emission tomography (PET)/computed tomography (CT) imaging of TNBC. The novel imaging agent showed good radiochemical purity (∼99 %) and stability (∼95 % in PBS and ∼99 % in cell medium after 48 h). Furthermore, the CCm-PEG-89Zr-BP-PSi NPs had efficient homotypic targeting ability in vitro and in vivo for TNBC. These findings demonstrate a versatile biomimetic coating method to prepare novel NPs for tumor-targeted diagnosis.

22 October 2023 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
HWHuang Wen
Huang Wen
PPPekka Poutiainen
Pekka Poutiainen
EBEnkhzaya Batnasan
Enkhzaya Batnasan
Leena LatonenLeena Latonen
Leena Latonen
VLVesa-Pekka Lehto
Vesa-Pekka Lehto
Wujun XuWujun Xu
Wujun Xu
Mesoporous silicon nanoparticles (PSi NPs) are promising platforms of nanomedicine because of their good compatibility, high payload capacities of anticancer drugs, and easy chemical modification. Here, PSi surfaces were functionalized with bisphosphonates (BP) for radiolabeling, loaded with doxorubicin (DOX) for chemotherapy, and the NPs were coated with cancer cell membrane (CCm) for homotypic cancer targeting. To enhance the CCm coating, the NP surfaces were covered with polyethylene glycol prior to the CCm coating. The effects of the BP amount and pH conditions on the radiolabeling efficacy were studied. The maximum BP was (2.27 wt%) on the PSi surfaces, and higher radiochemical yields were obtained for 99mTc (97% ± 2%) and 68Ga (94.6% ± 0.2%) under optimized pH conditions (pH = 5). The biomimetic NPs exhibited a good radiochemical and colloidal stability in phosphate-buffered saline and cell medium. In vitro studies demonstrated that the biomimetic NPs exhibited an enhanced cellular uptake and increased delivery of DOX to cancer cells, resulting in better chemotherapy than free DOX or pure NPs. Altogether, these findings indicate the potential of the developed platform for cancer treatment and diagnosis.

31 January 2024 in Inorganic Chemistry
Verified
Journal Article
Closed access
HHHua Huang
Hua Huang
HWHuang Wen
Huang Wen
XGXiaoying Gao
Xiaoying Gao
YLYunjia Liu
Yunjia Liu
HWHua Wei
Hua Wei
JLJian Liu
Jian Liu

4 September 2024 in Inorganic Chemistry
Verified
Journal Article
Closed access
JZJiahui Zhao
Jiahui Zhao
YZYixuan Zhao
Yixuan Zhao
XSXuefeng Shao
Xuefeng Shao
YSYing Sun
Ying Sun
HWHuang Wen
Huang Wen
JLJian Liu
Jian Liu